DOI:
10.1055/s-00035037
Methods of Information in Medicine
LinksClose Window
References
FDA. FDA Drug Safety Communication: Update to ongoing safety review of Actos (pioglitazone) and increased risk of bladder cancer. 2011 (Cited Feb 25, 2012.) Available from.
http://www.fda.gov/Drugs/DrugSafety/ucm259150.htm
We do not assume any responsibility for the contents of the web pages of other providers.